Chemistry: analytical and immunological testing – Involving producing or treating antigen or hapten – Producing labeled antigens
Patent
1981-08-13
1984-06-05
Nucker, Christine M.
Chemistry: analytical and immunological testing
Involving producing or treating antigen or hapten
Producing labeled antigens
436547, 436804, 436813, 260112R, 260112B, 2601125R, C07C10352, C07C 700, G01N 3358, G01N 3360
Patent
active
044529040
ABSTRACT:
This disclosure relates to assay of a glycoprotein component of human breast gross cystic disease fluid which has been designated GCDFP-15. This material is a useful marker in monitoring the efficacy of therapy in women with metastatic breast carcinoma and also in determining the maturity of the fetus in pregnant women. The assay for GCDFP-15 can also be used in conjunction with other assays for breast carcinoma such as an assay for carcinoembryonic antigen (CEA) whereby the utilization of both tests is more effective in monitoring for recurrence of disease than using either assay alone.
REFERENCES:
patent: 4229426 (1980-10-01), Haagensen, Jr.
Haagensen, Jr. et al., Annals of Surgery, 185, (3), 279-285, (1977).
Haagensen, Jr. et al., J. Natl. Cancer Inst., 62, (2), 239-247, (1979).
Duke University
Gould George M.
Maitner John J.
Nucker Christine M.
Saxe John S.
LandOfFree
Breast cyst fluid protein assay does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Breast cyst fluid protein assay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Breast cyst fluid protein assay will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1497899